The world is caught in a perfect storm of rising rates of chronic disease, persistent infectious diseases and public health failures that have fuelled deaths in the Covid-19 pandemic, according to a major global study of human health.

The Bloc’s Dan Sontupe explores why the failure to educate patients about their conditions and treatment plans is a far bigger driver of healthcare costs than the price of prescription drugs.

Few nutritional supplements can protect people from developing or dying from cardiovascular disease, and some may actually be harmful, a research review suggests.

Shares of Immune Design skyrocketed after Merck announced the acquisition of the Seattle-based oncology company for $300 million in cash.

Drugstore chain Walgreens Boots Alliance Inc. and Microsoft Corp said they have entered a seven-year agreement to research and develop new methods of delivering healthcare services through digital devices.

With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to become a broad healthcare provider in China.

PureTech Health plc entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to advance PureTech’s milk-derived exosome platform technology for the oral administration of Roche’s antisense oligonucleotide platform.

Danish drugmaker Novo Nordisk and aid agency Red Cross have teamed up to try to improve the treatment of chronic diseases among the millions affected by conflicts and humanitarian crises in countries such as Syria and Yemen.

Havas Health & You, a global leader in health-and-wellness communications, announced a strategic partnership with Lyfebulb, a patient empowerment platform that promotes a healthy, take-charge lifestyle for those affected by chronic disease.

When asked to characterize the overall health of top performers in their companies, 65% of U.S. employees said they were just “somewhat” healthy.